Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products

Forensic Science International

Volumn 243, Issue , 2014, Pages 1-13

  Uchiyama, Nahoko ^a   Matsuda, Satoru ^a   Kawamura, Maiko ^a   Shimokawa, Yoshihiko ^a   Kikura Hanajiri, Ruri ^a   Aritake, Kosuke ^b   Urade, Yoshihiro ^b   Goda, Yukihiro ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

3,4 Dichloromethylphenidate; 5 Chloro NNEI; Cathinone derivative; NNEI indazole analog; Synthetic cannabinoid

Indexed keywords

3,4 DICHLOROMETHYLPHENIDATE; 3,4 DIMETHOXY ALPHA PYRROLIDINOHEXYLPHENONE; 4 FLUORO ALPHA PYRROLIDINOHEXYLPHENONE; 4 METHYL ALPHA PYRROLIDINOHEXYLPHENONE; 5 CHLORO[N(NAPHTHALEN 1 YL) 1 PENTYL 1H INDAZOLE 3 CARBOXAMIDE]; 5 FLUORO[N(NAPHTHALEN 1 YL) 1 PENTYL 1H INDAZOLE 3 CARBOXAMIDE]; ALPHA ETHYLAMINOPENTIOPHENONE; ALPHA PYRROLIDINO OCTANOPHENONE; ALPHA PYRROLIDINOHEXYLPHENONE; CANNABINOID RECEPTOR ANTAGONIST; CATHINONE; INDAZOLE DERIVATIVE; UNCLASSIFIED DRUG; [2 (ETHYLAMINO) 1 (RHO TOLYL)PENTAN 1 ONE (N ETHYL 4 METHYL PENTEDRONE 4 METHYL ALPHA ETHYLAMINOPENTIOPHENONE)]; 2 (ETHYLAMINO) 1 (4 TOLYL)PENTAN 1 ONE; 4 METHYL ALPHA ETHYLAMINOPENTIOPHENONE; ALPHA PYRROLIDINOHEPTANOPHENONE; ALPHA PYRROLIDINOOCTANOPHENONE; CANNABINOID; DESIGNER DRUG; ILLICIT DRUG; LY 2183240; N (NAPHTHALEN 1 YL) 1 PENTYL 1H INDAZOLE 3 CARBOXAMIDE; N ETHYL 4 METHYLPENTEDRONE; ALKALOID; CENTRAL STIMULANT AGENT; LY2183240; METHYLPHENIDATE; PLANT MEDICINAL PRODUCT; PSYCHOTROPIC AGENT; SINGLE HETEROCYCLIC RINGS; UREA;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; DRUG TRAFFIC; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; JAPAN; QUALITATIVE ANALYSIS; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG LEGISLATION; SUBSTANCE-RELATED DISORDERS;

ALKALOIDS; CANNABINOIDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DESIGNER DRUGS; HETEROCYCLIC COMPOUNDS, 1-RING; JAPAN; LEGISLATION, DRUG; METHYLPHENIDATE; PLANT PREPARATIONS; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; UREA;

EID: 84899066751     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2014.03.013     Document Type: Article

References (19)

1. EMCDDA/Europol, 2005/387/JHA, EMCDDA-Europol 2012 Annual Report on the implementation of Council Decision, http://www.emcdda.europa.eu/publications/implementation-reports/2012 (accessed May 13).
2. UNODC. The challenge of new psychoactive substances. A Report from the Global SMART Programme, http://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf (access September 13).
3. Kikura-Hanajiri R., Uchiyama N., Kawamura M., Goda Y. Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan. Forensic Toxicol. 2013, 31:44-53.
4. Kikura-Hanajiri R., Uchiyama N., Kawamura M., Ogata J., Goda Y. Prevalence of new designer drugs and their legal status in Japan. Yakugaku Zasshi 2013, 133:31-40.
5. Uchiyama N., Matsuda S., Kawamura M., Kikura-Hanajiri R., Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol. 2013, 31:223-240.
6. N. Uchiyama, S. Matsuda, D. Wakana, R. Kikura-Hanajiri, Y. Goda, New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA), identified as designer drugs, Forensic Toxicol. 31 (2013) 93-100.
7. N. Uchiyama, S. Matsuda, M. Kawamura, R. Kikura-Hanajiri, Y. Goda, Identification of two new-type designer drugs, a piperazine derivative MT-45 (I-C6) and a synthetic peptide Noopept (GVS-111), with a synthetic cannabinoid A-834735, a cathinone derivative 4-methoxy-α-PVP and a phenethylamine derivative 4-methylbuphedrine from illegal products, Forensic Toxicol., 32 (2014) 9-18.
8. R. Kikura-Hanajiri, N. Uchiyama, M. Kawamura, Y. Goda, Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan, Drug Test. Anal., online available. doi:10.1002/dta.1584.
9. N. Uchiyama, Kawamura, R. Kikura-Hanajiri, Y. Goda, URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products, Forensic Sci. Int. 227 (2013) 21-32.
10. Blaazer A.R., Lange J.H., van der Neut M.A., Mulder A., den Boon F.S., Werkman T.R., Kruse C.G., Wadman W.J. Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: design, synthesis, structure-activity relationships, physicochemical proper. Eur. J. Med. Chem. 2011, 46:5086-5098.
11. Shevyrin V., Melkozerov V., Nevero A., Eltsov O., Morzherin Y., Shafran Y. Analytical characterization of some synthetic cannabinoids, derivatives of indole-3-carboxylic acid. Forensic Sci. Int. 2013, 232:1-10.
12. Moore S.A., Nomikos G.G., Dickason-Chesterfield A.K., Schober D.A., Schaus J.M., Ying B.P., Xu Y.C., Phebus L., Simmons R.M., Li D., Iyengar S., Felder C.C. Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:17852-17857.
13. Ortar G., Cascio M.G., Moriello A.S., Camalli M., Morera E., Nalli M., Di Marzo V. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. Eur. J. Med. Chem. 2008, 43:62-72.
14. Westphal F., Junge T., Rösner P., Fritschi G., Klein B., Girreser U. Mass spectral and NMR spectral data of two new designer drugs with an α-aminophenone structure: 4[U+02B9]-methyl-α-pyrrolidinohexanophenone and 4[U+02B9]-methyl-α-pyrrolidinobutyrophenone. Forensic Sci. Int. 2007, 169:32-42.
15. Sauer C., Hoffmann K., Schimmel U., Peters F.T. Acute poisoning involving the pyrrolidinophenone-type designer drug 4[U+02B9]-methyl-alpha-pyrrolidinohexanophenone (MPHP). Forensic Sci. Int. 2011, 208:e20-e25.
16. Meltzer P.C., Butler D., Deschamps J.R., Madras B.K. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J. Med. Chem. 2006, 49:1420-1432.
17. α-Aminoketone derivatives, Patent, GB 1069797 19670524 (1967).
18. Schweri M.M., Deutsch H.M., Massey A.T., Holtzman S.G. Biochemical and behavioral characterization of novel methylphenidate analogs. J. Pharmacol. Exp. Ther. 2002, 301:527-535.
19. Monte A.P., Marona-Lewicka D., Cozzi N.V., Nichols D.E. Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine. J. Med. Chem. 1993, 36:3700-3706.